GLP-1, incretin multi-agonist and amylin trial starts by region

3 regions, 2020 to 2025

223 Global, 2025

GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025). 0 50 100 150 200 250 2020 2021 2022 2023 2024 2025 Global United States China
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
View the underlying data
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 223
Global 2024 Actual 191
Global 2023 Actual 142
Global 2022 Actual 104
Global 2021 Actual 101
Global 2020 Actual 66
United States 2025 Actual 107
United States 2024 Actual 98
United States 2023 Actual 70
United States 2022 Actual 42
United States 2021 Actual 51
United States 2020 Actual 20
China 2025 Actual 54
China 2024 Actual 36
China 1 Jan 2023 to 27 Sep 2026 Actual 178
China 2022 Actual 21
China 2021 Actual 18
China 2020 Actual 16
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0